Friday, May 19, 2017 2:33:45 PM
Found the notes below at
http://iposgoode.ca/TheUSPatentLitigationProcess-IPOsgoodeDecember2010.pdf
pg 4, 2nd paragraph:
If the defendant has asserted counterclaims (e.g.,
asserting that the plaintiff’s patent is invalid), the
plaintiff must serve a reply, which is the plaintiff’s
answer to the counterclaims. The plaintiff is
required to respond to counterclaims in the same
manner as the defendant is required to respond to the
plaintiff’s claims—that is, by either denying or
admitting the allegations. Replies are due within 21
days after being served with the counterclaims.
Authored in Dec 2010 by:
Irfan A. Lateef is a Partner at Knobbe Martens in
Irvine, California. He is a graduate of Georgetown
University Law Center (J.D.), Northwestern
University (M.S. Biomedical Engineering), and
University of Illinois, Urbana-Champaign
(B.S.E.E.).
Marko R. Zoretic is a Partner at Knobbe Martens in
Irvine, California and is the president of the
Canadian American Bar Association. He is a
graduate of McMaster University (Electrical
Engineering and Management) in Hamilton, Ontario
and Osgoode Hall Law School (J.D.) in Toronto,
Ontario.
Don't know how much(if at all) things have changed since 2010.
Pg 7 of their paper notes "If a patent infringement lawsuit makes it to trial—and less than 5% do—it will likely be a trial
by jury. The parties may waive the right to a jury
trial and have the court try the case, but such waivers
are rare."
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
- L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - IPCI • PR Newswire (Canada) • 06/08/2023 05:30:00 PM
- Canadian Investment Regulatory Organization Trade Resumption - IPCI • PR Newswire (Canada) • 06/08/2023 05:28:00 PM
- Intellipharmaceutics Announces Fiscal Year 2022 and First Quarter 2023 Results • PR Newswire (Canada) • 06/06/2023 10:00:00 AM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM